Focus on Ovarian and Gynecologic Cancers
In the wake of Angelina Jolie’s announcement that she carries a genetic mutation linked to breast and ovarian cancers, thousands of women are wondering whether they are at risk. To address their concerns, four women’s health organizations have joined together to provide essential information about risk factors and symptoms of ovarian cancer.
A new study suggests that the common diabetes medication metformin may be considered for use in the prevention or treatment of ovarian cancer. Published in CANCER, a journal of the American Cancer Society, the study found that women with ovarian cancer who took the drug tended to live longer than those who did not take it.
As cancer survival rates improve, there is an increasing need for simple, user-friendly resources that help survivors document their care and plan for life after cancer. To fill the void for this type of information for survivors of gynecologic cancers, the Foundation for Gynecologic Oncology is making available to patients and doctors a set of gynecologic cancer survivorship tools beginning in September, Gynecologic Cancer Awareness Month.